Today, a Director at CHF Solutions Inc (NASDAQ: CHFS), Gregory Waller, sold shares of CHFS for $74.
This is Waller’s first transaction since reporting a Sell transaction on ELGX back in June 2016
See today’s analyst top recommended stocks >>
Based on CHF Solutions Inc’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $1.1 million and GAAP net loss of $4.18 million. In comparison, last year the company earned revenue of $864K and had a GAAP net loss of $2.46 million. Currently, CHF Solutions Inc has an average volume of 67.49K.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CHF Solutions, Inc. is a medical device company, which engages in the provision of products for the treatment of fluid overload specifically for cardiac and coronary diseases. It engages in the development, manufacture, and commercialization of Aquadex FlexFlow System, which provides an ultrafiltration treatment for patients with failed diuretic therapy and require hospitalization. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
